Mononuclear phagocytes in therapeutic drug delivery

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 48/00 (2006.01) A61K 47/48 (2006.01)

Patent

CA 2268417

The invention relates to the exploitation of the migratory behaviour of mononuclear phagocytes with a view to targeting therapeutic drug delivery. The invention therefore concerns the attachment or incorporation of a therapeutic agent to or into a mononuclear phagocyte and the subsequent migration of the munonuclear phagocyte to a target area.

Cette invention concerne l'exploitation du comportement migratoire des phagocytes mononucléaires en vue de diriger l'apport de médicament thérapeutique sur une cible spécifique, et par conséquent la fixation d'un agent thérapeutique sur un phagocyte mononucléaire ou son intégration dans un phagocyte mononucléaire suivie par la migration subséquente dudit phagocyte mononucléaire jusqu'à une région cible.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Mononuclear phagocytes in therapeutic drug delivery does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mononuclear phagocytes in therapeutic drug delivery, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mononuclear phagocytes in therapeutic drug delivery will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1436736

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.